| 21 |
The transcription factor ZEB-1 conveys chemoresistance in breast cancer |
2024 |
| 22 |
CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt |
2023 |
| 23 |
FOS-Like Antigen 1 Expression Was Associated With Survival of Hepatocellular Carcinoma Patients |
2023 |
| 24 |
FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy |
2023 |
| 25 |
Prognostic Effect of Nodular and Infiltrating Tumor deposits of colorectal carcinoma and its relation to neoadjuvant therapy a retrospective study |
2023 |
| 26 |
Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma |
2023 |
| 27 |
Signet ring cell component predicts the response to neoadjuvant chemoradiotherapy in rectal cancer. Long interim results of a single institution experience |
2022 |
| 28 |
Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents |
2021 |
| 29 |
Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents |
2021 |
| 30 |
Assessment of the clinical value of red cell distribution width in patients with de novo hepatocellular carcinoma following HCV clearance with the direct-acting antiviral agents |
2021 |